drugset / Trial / NCT00417144

Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients

NCT00417144 ↗

Phase 4 Unknown 200 enrolled Eugonia
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to compare pregnancy rates and the occurrence of OHSS in PCOS patients who were treated with GnRH agonist and GnRH antagonist protocols ovarian stimulation during an IVF cycle. Our hypothesis is that the GnRH antagonist protocol reduces the occurrence and severity of OHSS compared to the GnRH agonist protocol.

Timeline

Start
2003-11
Primary completion
—
Completion
2007-05

Outcome

Missed primary endpoint

paper No differences were observed in ongoing pregnancy rates [50.9 versus 47.3%, difference 3.6%, 95% confidence interval (CI): -9.6 to +16.8%] PMID 20008886 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ganirelix Protein / enzyme biologic 0.25 mg —
Subject Triptorelin Other / unclassified 0.1 mg —